Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Project

Signature bioenergetics in the progression of the non-muscle invasive bladder cancer: PTIs, PTA, pT1

Funder: São Paulo Research Foundation

Funding period
0
Funding amount
Abstract
The understanding of how cancer cells are able to ensure a positive energy balance and associate it with anabolic processes is vital to the development of effective therapies against cancer. These facts make the study of the association of non-muscle invasive bladder cancer (NMIBC) with the energy metabolism of particular importance, and are able to generate important advances in the understanding of these tumors, especially when you relate and compared these events with baseline normal and a cell. Thus, the general objectives of this study are to characterize and compare cellular energy metabolism profiles in different histological grades (pTis, pTa, pT1) of NMIBC to be possible to establish a criterion of clinical pathological significance and prognostic for the classification of these tumors . In this work will be used 20 tissue samples of the urinary bladder in men aged 60-90 years with or without a diagnosis of urothelial lesions, obtained from the Amaral Carvalho Hospital of Jaú-SP Urology Service. Five bladder samples will come from autopsies of patients without a diagnosis of urothelial lesions and / or urologic disease. In addition, the other 15 bladder samples will come from a retrospective study of patients undergoing transurethral resection (TUR) and / or radical cystectomy. Patients will be divided into 4 groups (5 samples each): Normal Group (without injury); Non-Muscle Invasive group pTis; Non-Muscle Invasive group pTa and Non-Muscle Invasive pT1 group. Next, the samples will be subjected to histopathological and immunohistochemical analyzes. From this project is expected to obtain greater knowledge on energy metabolism, so that these relationships can be an important tool for the diagnosis and management of patients with NMIBC.
Similar projects All >
Sorted by: Start Date
Project list item
Intravesical delivery of an Fc-enhanced CD40 agonist antibody for the treatment of bladder cancer

Bladder Cancer Advocacy Network to Jeffrey Ravetch, David Knorr

USD 300,000
2020 - 2022
Project list item
Epigenetic regulators of subtype plasticity in bladder cancer

Bladder Cancer Advocacy Network to John Robert Christin

USD 1,700
2020 - 2020
Project list item
Defining NRF2 induced tumor invasion in bladder cancer

Bladder Cancer Advocacy Network to Yuki Kita, William Youngkwan Kim, Bernard Weissman

USD 50,000
2020 - 2021
Project list item
Dissecting myeloid cell-mediated resistance to immune checkpoint blockade in bladder cancer

National Cancer Institute to NINA BHARDWAJ, JUN ZHU, MATTHEW GALSKY

USD 703,400
2020 - 2025

System

Categories
  • FOR (ANZSRC)

    1112 Oncology and Carcinogenesis

  • RCDC

    Cancer

  • RCDC

    Clinical Research

  • RCDC

    Urologic Diseases

  • HRCS HC

    Cancer

  • HRCS RAC

    2.1 Biological and endogenous factors

  • Health Research Areas

    Biomedical

  • Broad Research Areas

    Clinical Medicine and Science